FDA Issues Guidance on Controlling Elemental Impurities in Drugs

Drug GMP Report
A A
The FDA finalized its recommendations on how drug sponsors submitting applications should control elemental impurities in their drug products.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00